InnoLead and B Capital brought together more than three dozen innovators and corporate venture capital investors in Manhattan in April. They convened around a number of topics, including generative AI and emerging technologies, growing innovation teams in times of financial trouble, and changing dynamics in the venture capital sphere. The event, held at B Capital’s office in Hudson Yards, brought together participants from a range of industries and companies, including Citi, Pfizer, Walmart, Novartis, Ralph Lauren, Verizon, and many more. Thanks to the B Capital team for hosting!
Our next in-person event takes place May 17th in Boston: Leveraging A.I. in Business.
Rob May, CEO of Nova.ai (at left) and Brian Chin of Santander Fintech Station connect as the event gets started.
Dov Shamir of the Icahn School of Medicine at Mount Sinai, Jordan Brehove of Taak, Inc.; and Ahmet-Hamdi Cavusoglu of Merck Digital Science, chat during networking time.
InnoLead CEO Scott Kirsner, and Paulina Karpis, Director, Early-Stage Platform and Community at B Capital, welcome the group.
Attendees broke out into six table discussions to share challenges, opportunities, and advice.
A group of attendees engage in a table discussion about defending innovation activities — and attracting additional resources.
Katie Skibinski, Chief Innovation Officer of Planned Parenthood, shares her perspectives during a table discussion.
A group of attendees discuss generative AI and emerging technology in their organizations.
Attendees lead a conversation about corporate VC and scouting promising startups.
Kangee Kaneene, VP of SAP’s startup accelerators, SAP.iO.
Former Citi VP Ashlyn Lackey and Carina Oriel, Community Development Lead, Rise New York.
Alana Kanter, VP of Marketing and Communications at B Capital.
Attendees participated in an impromptu rock, paper, scissors competition to wrap up the afternoon.
/
Photos by Cara Estol.
